George Joseph, MD
Clinical Cardiac Electrophysiology · Weirton, WVNPI 1699766931
Payments from drug & device makers
Across 669 payments — averaging $212.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$42K
- Johnson & Johnson$35K
- Boehringer Ingelheim$30K
- Abbott$9K
- Medtronic$7K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$7K
- plus $13K from 30 others
What the payments were for
- Consulting fees$1,4251%
- Speaking & faculty fees$74,52577%
- Travel & lodging$8,2089%
- Food & beverage$11,51212%
- Education$8441%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 46 | $41,578 |
| Johnson & Johnson(2 entities) | 132 | $34,587 |
| Boehringer Ingelheim | 68 | $30,398 |
| Abbott | 58 | $8,803 |
| Medtronic(2 entities) | 134 | $7,297 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 104 | $6,595 |
| Lilly USA, LLC | 6 | $4,573 |
| Lundbeck LLC | 7 | $3,461 |
| Philips North America LLC | 12 | $2,389 |
| Novartis | 29 | $447 |
| Biotronik Inc. | 6 | $283 |
| Irhythm Technologies, Inc. | 2 | $244 |
| Cardiva Medical, Inc. | 4 | $235 |
| Janssen Research & Development, LLC | 1 | $232 |
| Amgen | 14 | $203 |
| Impulse Dynamics (USA) Inc. | 1 | $170 |
| AstraZeneca | 9 | $133 |
| Cook Medical LLC | 3 | $122 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $85 |
| E.r. Squibb & Sons, L.L.C. | 5 | $74 |
| Cvrx, Inc. | 1 | $52 |
| Sanofi-aventis U.S. LLC | 2 | $48 |
| Pfizer | 3 | $37 |
| Abiomed | 1 | $34 |
| Amarin Pharma, Inc. | 2 | $34 |
| Elutia, Inc. | 2 | $29 |
| Aurinia Pharma U.S., Inc. | 1 | $28 |
| Vifor Pharma, Inc. | 2 | $25 |
| Teleflex LLC | 1 | $21 |
| Intercept Pharmaceuticals, Inc. | 1 | $16 |
| Celonova Biosciences, Inc. | 1 | $16 |
| Esperion Therapeutics, Inc. | 1 | $15 |
| Cardiofocus, Inc. | 1 | $14 |
| ZOLL Circulation Inc | 1 | $14 |
| Corcept Therapeutics | 1 | $13 |
| Novo Nordisk | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- JARDIANCE$34,162
- XARELTO$33,344
- LifeVest$5,750
- NORTHERA$3,413
- AVEIR$1,146
- (9124) LM Undivided$1,142
- (9520) IGT Devices Undivided$1,016
- ENSITE PRECISION$746
- Ensite Cardiac Mapping System$561
- OPTIMIZER$340
- Micra$332
- EnSite Precision Cardiac Mapping System$328
- WATCHMAN Access System$319
- BioMonitor$162
- ZIO XT Patch$148
- Cardiva VASCADE MVP VVCS 6-12F$135
- Reveal LINQ$122
- RHYTHMIA$113
- LINQ II$107
- Attain$104
How this compares
Too few clinical cardiac electrophysiology providers in West Virginiato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 243 | $160,228 |
| XareltoRivaroxaban | 86 | $55,640 |
| Dofetilide | 217 | $37,441 |
| Metoprolol Succinate | 266 | $3,690 |
| Flecainide Acetate | 132 | $3,371 |
| Amiodarone Hcl | 224 | $2,632 |
| Mexiletine Hcl | 27 | $1,580 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 45 | $1,329 |
| Clindamycin Hcl | 160 | $1,001 |
| SotalolSotalol Hcl | 43 | $565 |
| Carvedilol | 57 | $492 |
| Potassium Chloride | 22 | $400 |
| Doxycycline Hyclate | 27 | $165 |
| Valsartan | 12 | $158 |
| Metoprolol Tartrate | 23 | $106 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $37 | $160,228243 claims |
| Johnson & JohnsonXarelto | $34,587 | $55,64086 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few clinical cardiac electrophysiology providers in West Virginiaon file to place this against a meaningful peer group, so we don't.
Other clinical cardiac electrophysiology in Weirton
- Christopher KolibashWeirton$42K
- Glen MiskeWeirton$39K
- Chafik AssalCharleston$204K
- Aamir CheemaHuntington$123K
- Khalid AbozguiaHuntington$73K
- Salam SbaityMorgantown$50K
- Latoya Linton-FrazierMorgantown$36K
- Tania BabarCharleston$29K
- Robert HullMorgantown$17K
- Alexey SergeevMorgantown$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.